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ABSTRACT
This study was conducted to evaluate the inhibitory activity of Sandoricum 
koetjape Merr. leaf extract to blood type O fibrin formation, where warfarin 
(positive), negative control and different extract concentrations (50%, 75% and 
100%) were compared. The computed F-value for the treatment was 238 with 
degrees of freedom 2.7. For replication, the computed F-value obtained was 3 
with degrees of freedom 2.7. The former F-value was significant at 0.5 and 0.1 
level of probability and the latter, was not significant. Results showed that 100% concentration has the highest time of coagulation but replication was almost the 
same.
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I. INTRODUCTIONCoagulation is the process by 
which blood forms clots (Finkel, Clark & 
Cubeddu, 2009). It is an important part of haemostasis, the cessation of blood loss from a damaged vessel, wherein a damaged blood vessel wall is covered by a platelet and fibrin-containing clot to stop bleeding and begin repair 
of the damaged vessel.  Disorders of coagulation 
can lead to an increased risk of bleeding or 
obstructive clotting. Coagulation begins almost instantly after an injury to the blood vessel has 
damaged the endothelium lining of the vessel. Cardiovascular disorders such as hypertension 
and thrombosis are well known in adults including arteriosclerosis and congestive heart failure which is caused by problem in blood circulatory system as blood clotting 
disorders constitute a serious medical problem. 
Warfarin and heparin and also an antiplatelet agent such as aspirin are used in disorders of 
coagulation (Zehnder,  2012; Martin, 2009; ). 
Blood-clot strokes can also happen as the result of unhealthy blood vessels clogged with a build 
up of fatty deposits and cholesterol. The human body regards these buildups as multiple, tiny 
and repeated injuries to the blood vessel wall. So the body reacts to these injuries just as it would if you were bleeding from a wound; it 
responds by forming clots. According to the 2012 morbidity and 
mortality chart book on cardiovascular, lung, 
and blood diseases, stroke ranked seventh for 
those people aging from 45-64 years and fourth 
on those aged 65 years and older  in 2008. Heart disease was the third leading cause of death for 
those aged 25-44 years, second for those aged 
45-64 years, and first for those aged 65 years 
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In this study, the inhibitory activities of the herbal plant extracts against coagulase production in S. aureus were assessed through 
Tube Coagulase Test and MHA colony count. The resulting clot in each tube was measured and 
the growth of colonies in MHA was counted. The results for the Tube Coagulase Test and colony count revealed that only the plant extract of E. hirta 
(GATAS-GATAS) and C. aromaticus (OREGANO) showed inhibitory activity against the production of coagulase in S. aureus. Furthermore, the P. rubra (KALACHUCHI) and I. aquatica (KANGKONG) plant extracts were effective in inhibiting the coagulase production due to its antibacterial activity against the bacteria S. aureus. Meanwhile the plat extract of M. pudica (MAKAHIYA) did not show any inhibitory activity against S. aureus 
coagulase production. 
VIII. CONCLUSIONThe results obtained from the measurement of grade level, turbidity and colony count showed that E. hirta (GATAS-GATAS) and C. aromaticus 
(OREGANO) plant extracts have inhibitory activity against the production of coagulase in 
S. aureus. The inhibitory activity might be due to the synergistic effects of its constituents or the presence of bioactive compounds of the 
two herbal plant extracts. The results of this study do not prove that plant extracts of E. hirta 
(GATAS-GATAS) and C. aromaticus (OREGANO) 
already has therapeutic value. The in vitro tests conducted do not, in any way, stimulate the 
complexity of the human body. Instead, these results warrant the E. hirta (GATAS-GATAS) and C. 
aromaticus (OREGANO) plant extracts to further 
anti-coagulase investigation.
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older. Based on the chart 2-14 and 2-15 of the 
chart book heart disease, stroke and chronic lower respiratory disease were the second, third, and sixth leading causes of death of 
Asian males and heart disease and stroke were the second and third leading cause of death 
to the Asian females. In a in vitro study of the anticoagulant activity of some plant extracts that the consumption of dietary anticoagulants that contain blood thinning activity can ultimately 
reduce or eliminate the risk of thromboembolic 
diseases (Al-saadi, 2013). This study justifies that there are traditional or plant extracts that 
can lower the risk of thromboembolic disease 
(Kumar, Joseph, George, & Sharma, 2011).
Santol is credited for its numerous folkloric 
uses which are still used. Fresh leaves applied to 
the skin are sudorific, and used by the Ifugaos for 
diarrhea. Decoction or infusion of leaves used 
for baths to reduce fever. Also, used for diarrhea 
and as a tonic after childbirth. Bark poultice 
used for ringworm. Bitter roots, bruised with vinegar and water, is a carminative; used for 
diarrhea and dysentery. Pounded barks applied 
to ringworm. Leaves used for skin infections 
and rashes. Roots used as tonic (Godofredo 
2013).
In everyday life, blood clotting is beneficial. Anticoagulants which are also called blood 
thinners work by interrupting part of the process involved in the formation of blood 
clots. This means that blood clots are less likely to form where they are not needed, but can still 
form when they are. Anticoagulants increase the 
time it takes the blood to clot thereby preventing 
harmful clots from forming and blocking blood flow, yet, can prevent existing clots from getting 
bigger.When you are bleeding from a wound, 
blood clots work to slow and eventually stop 
the bleeding. In the case of stroke, however, blood clots are dangerous because they can 
block arteries and cut off blood flow, a process 
called ischemia. An ischemic stroke can occur in 
two ways: embolic and thrombotic strokes.
This study, through  the wonder of santol may help in coming up with an option for combatting coagulation disorders specially to adults who may suffer and die due to 
complication. The study can likewise introduce a cheaper and more accessible anticoagulant 
alternative as the plant is locally found. 
II. OBJECTIVESThe purpose of the study is to determine the inhibitory activity of Sandoricum koetjape 
Merr. (santol) leaf extract to blood type O fibrin 
formation.  Specifically, the study aimed to: 
1.	 Determine the onset of action (i.e. coagulation time) of the plant extract in terms of:
1.1	 50% concentration
1.2	 75% concentration
1.3	 100% concentration
2.	 Determine the clotting activity of the blood plasma after administration of plant 
extract using clot test score.
3.	 Compare the inhibitory effect of 
Sandoricum koetjape leaf extract to that of 
Aspirin (positive control).
III. MATERIALS AND METHODS
Collection and Preparation of Plant 
Sample. The leaves of Sandoricum koetjape 
Merr. was collected in Gullas Medical Hospital at the College of Medicine in Barangay Banilad, 
Mandaue city. It was authenticated by the 
Department of Agriculture.
Preparation of Leaves Extract. The collected materials was washed with water and 
dried on a shade. The dried leaves were crushed into powders and subjected to maceration for three days with methanol and occasionally 
shake. The marc is decanted to separate extract. Then methanol was evaporated through evaporating dish in a controlled temperature of 
heat.
Preparation of Experimental Blood. 
Three blood samples for  blood type “O” 
39
were taken to selected students of College of Pharmacy with healthy condition by using sterile syringes, withdrawn from vein of right arm and placed separately in a containers containing tri-sodium citrate to prevent the 
clotting process. Each person was taken 9ml 
of blood through Gullas Medical Hospital 
Laboratory. The bloods then were centrifuged 
for 15 minutes at rate of 3000 rpm to separate blood cells from plasma in order to obtain pure 
platelet plasma for prothrombin time test. The obtained plasma samples of each individual were poured separately in plane containers 
using syringes ant stored at room temperature. 
Collection of blood and Plasma re-
calcification. 0.2 ml plasma, 0.1 ml of crude extract of different concentration and different 
volume of CaCl2 (25 mM) were fused together 
in a plain capillary tube. For control experiment extract solution was replaced by same volume 
of 0.9% saline water. The clotting time was recorded with stopwatch by tilting the capillary 
tube every 5 seconds. This time is called the 
prothrombin time.
Clot Test Score. The tests were scored as (4+) where the fibrin clot fills the complete volume, (3+) where the clot fills more than half but less than the total volume, (2+) where the clot fills less than half the total volume, and 
(1+) where there is a little disorganized clot formation; (negative) no clot observed but little 
amorphous deposit might be seen. All of the 
tests were carried out in duplication.
Collection of Crude Extract by 
Maceration. Figure 1.1 Preparation of test plant by maceration, starting point is collection of leaves and dried under shade at room temperature and when all the leaves are dried then it is powdered and weighed 60g submerged 
to 150mL of methanol and macerated for three 
days, to make the leaves exhausted it is covered 
and occasionally shakes. After three days, the mixture is evaporated over evaporating dish to let the methanol to evaporate and remained 
the crude extract of the leaves.  Dried extract is 
stored at 200C until used.
Research Flow. To enable us to start with the experiment proper, the collection of fresh leaves and collection of blood samples was 
one of the things that are being considered. First,  the collection and washing of fresh leaves, then right after then was the drying of it under-shade, when the leaves were dried it was then powdered and macerated with methanol 
for three days with occasional shaking of 
the container. Then, the solution must be separated from the powdered leaves; muslin 
cloth was used to totally get the extractives. The extractives are subjected to evaporation 
to get the solid crude extract. Second, the collection of blood sample, prior to that was the selection of healthy student who bears a type O 
blood. The blood was extracted by a registered medical technologist in the hospital laboratory where the centrifugation of the blood sample is 
also done. The centrifugation of blood sample is one way to separate the plasma from the 
blood; the plasma is placed in other container. Lastly, was the conduction of the experiment proper but prior to it was the preparation of 
the crude extract of different concentrations. For the controlling groups which consists of the positive and negative controls the conduction 
is separated from the experimental groups. For 
the 100%, plasma is 0.2mL added with 0.1mL 
of plant extract and 0.3mL of calcium chloride, 
50% has 0.2mL of plasma added with 0.1mL 
of plant extract and 0.1mL of calcium chloride, 
and for the 75%, plasma is 0.2mL added 
with 0.1mL of extract and 0.2mL of calcium 
chloride. As observed, the calcium chloride has different volume in every different level of 
concentrations. After the administration of the extract to plasma it was incubated in a water 
bath with 370C and checks every single time. For 
the said positive control using warfarin a 0.2mL 
of plasma was added with 0.1mL of warfarin 
5mg and 0.3mL of calcium chloride and instead 
of incubation it was tilted every 5 seconds.
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chart book heart disease, stroke and chronic lower respiratory disease were the second, third, and sixth leading causes of death of 
Asian males and heart disease and stroke were the second and third leading cause of death 
to the Asian females. In a in vitro study of the anticoagulant activity of some plant extracts that the consumption of dietary anticoagulants that contain blood thinning activity can ultimately 
reduce or eliminate the risk of thromboembolic 
diseases (Al-saadi, 2013). This study justifies that there are traditional or plant extracts that 
can lower the risk of thromboembolic disease 
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diarrhea. Decoction or infusion of leaves used 
for baths to reduce fever. Also, used for diarrhea 
and as a tonic after childbirth. Bark poultice 
used for ringworm. Bitter roots, bruised with vinegar and water, is a carminative; used for 
diarrhea and dysentery. Pounded barks applied 
to ringworm. Leaves used for skin infections 
and rashes. Roots used as tonic (Godofredo 
2013).
In everyday life, blood clotting is beneficial. Anticoagulants which are also called blood 
thinners work by interrupting part of the process involved in the formation of blood 
clots. This means that blood clots are less likely to form where they are not needed, but can still 
form when they are. Anticoagulants increase the 
time it takes the blood to clot thereby preventing 
harmful clots from forming and blocking blood flow, yet, can prevent existing clots from getting 
bigger.When you are bleeding from a wound, 
blood clots work to slow and eventually stop 
the bleeding. In the case of stroke, however, blood clots are dangerous because they can 
block arteries and cut off blood flow, a process 
called ischemia. An ischemic stroke can occur in 
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complication. The study can likewise introduce a cheaper and more accessible anticoagulant 
alternative as the plant is locally found. 
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Department of Agriculture.
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dried on a shade. The dried leaves were crushed into powders and subjected to maceration for three days with methanol and occasionally 
shake. The marc is decanted to separate extract. Then methanol was evaporated through evaporating dish in a controlled temperature of 
heat.
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Three blood samples for  blood type “O” 
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were taken to selected students of College of Pharmacy with healthy condition by using sterile syringes, withdrawn from vein of right arm and placed separately in a containers containing tri-sodium citrate to prevent the 
clotting process. Each person was taken 9ml 
of blood through Gullas Medical Hospital 
Laboratory. The bloods then were centrifuged 
for 15 minutes at rate of 3000 rpm to separate blood cells from plasma in order to obtain pure 
platelet plasma for prothrombin time test. The obtained plasma samples of each individual were poured separately in plane containers 
using syringes ant stored at room temperature. 
Collection of blood and Plasma re-
calcification. 0.2 ml plasma, 0.1 ml of crude extract of different concentration and different 
volume of CaCl2 (25 mM) were fused together 
in a plain capillary tube. For control experiment extract solution was replaced by same volume 
of 0.9% saline water. The clotting time was recorded with stopwatch by tilting the capillary 
tube every 5 seconds. This time is called the 
prothrombin time.
Clot Test Score. The tests were scored as (4+) where the fibrin clot fills the complete volume, (3+) where the clot fills more than half but less than the total volume, (2+) where the clot fills less than half the total volume, and 
(1+) where there is a little disorganized clot formation; (negative) no clot observed but little 
amorphous deposit might be seen. All of the 
tests were carried out in duplication.
Collection of Crude Extract by 
Maceration. Figure 1.1 Preparation of test plant by maceration, starting point is collection of leaves and dried under shade at room temperature and when all the leaves are dried then it is powdered and weighed 60g submerged 
to 150mL of methanol and macerated for three 
days, to make the leaves exhausted it is covered 
and occasionally shakes. After three days, the mixture is evaporated over evaporating dish to let the methanol to evaporate and remained 
the crude extract of the leaves.  Dried extract is 
stored at 200C until used.
Research Flow. To enable us to start with the experiment proper, the collection of fresh leaves and collection of blood samples was 
one of the things that are being considered. First,  the collection and washing of fresh leaves, then right after then was the drying of it under-shade, when the leaves were dried it was then powdered and macerated with methanol 
for three days with occasional shaking of 
the container. Then, the solution must be separated from the powdered leaves; muslin 
cloth was used to totally get the extractives. The extractives are subjected to evaporation 
to get the solid crude extract. Second, the collection of blood sample, prior to that was the selection of healthy student who bears a type O 
blood. The blood was extracted by a registered medical technologist in the hospital laboratory where the centrifugation of the blood sample is 
also done. The centrifugation of blood sample is one way to separate the plasma from the 
blood; the plasma is placed in other container. Lastly, was the conduction of the experiment proper but prior to it was the preparation of 
the crude extract of different concentrations. For the controlling groups which consists of the positive and negative controls the conduction 
is separated from the experimental groups. For 
the 100%, plasma is 0.2mL added with 0.1mL 
of plant extract and 0.3mL of calcium chloride, 
50% has 0.2mL of plasma added with 0.1mL 
of plant extract and 0.1mL of calcium chloride, 
and for the 75%, plasma is 0.2mL added 
with 0.1mL of extract and 0.2mL of calcium 
chloride. As observed, the calcium chloride has different volume in every different level of 
concentrations. After the administration of the extract to plasma it was incubated in a water 
bath with 370C and checks every single time. For 
the said positive control using warfarin a 0.2mL 
of plasma was added with 0.1mL of warfarin 
5mg and 0.3mL of calcium chloride and instead 
of incubation it was tilted every 5 seconds.
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IV. RESULTS AND DISCUSSIONSThe experiment was then conducted for 
1 week. After three days of maceration and 
occasionally shaking to exhaust the constituents of the leaves then evaporated in a evaporating dish to let the methanol evaporates, the total yield collected of crude extract out of 60 grams 
of powdered leaves is 6.66 grams. The yield was then divided into three sets of concentration 
containing 2.2 grams of the yield crude extract. 
The 100% then had an equal amount of 2.2 grams, 
75% had 2.2 grams of crude extract the diluted to 
0.7mL of water, and 50% had then 2.2 grams of crude extract also diluted to a different volume of 
2mL. In every concentration and trials they were 
incubated to 370C in a water bath and checks 
every 30 minutes and recorded for any changes.
The above table serves as the baseline value 
of the blood plasma. This is the basis of the thinning time of blood after the administration of 
crude extract. As shown, the coagulation time of plasma before administration of plant extract was 
one minute.
The above table serves as the baseline value 
for the positive control using commercialized 
warfarin. As shown, the coagulation time of plasma after administration of warfarin was four 
minutes and one second.
Test Plasma(mL) 0.9% Saline (mL) Calcium chloride(mL) Coagulation Time(Minutes)Negative control 0.2 0.1 0.3 1.0
Test Plasma(mL) Warfarin 5mg(mL) Calcium chloride(mL) Coagulation Time(Minutes)Positive control 0.2 0.1 0.3 4.1 min
Table 4.1 Determination	 of	 baseline	 coagulation	 time	
using	saline	solution	for	the	control	of	plasma.
Table 4.3 Determination	 of	 coagulation	 time	 using	
methanol	extract	for	100%	concentration	of	crude	extract	
to	the	plasma	of	type	O	blood
Table 4.4 Determination	 of	 coagulation	 time	 using	
methanol	extract	for	75%	concentration	of	crude	extract	to	
the	plasma	of	type	O	blood.
Table 4.5 Determination	 of	 coagulation	 time	 using	
methanol	 extract	 for	 50%	concentration	 of	 crude	 extract	
of	a	blood	type	O.
Table 4.2 Determination	 of	 coagulation	 time	 using	
warfarin	5mg	to	a	blood	type	O.
This table shows that at 100% concentration 
the blood coagulation were 4.35 minutes, 4.14 
minutes , and 4.6 minutes which suggest that after the administration of crude extract until the time it coagulates there were  thinning formation which could be comparable to the time results of 
warfarin.
This table shows that at 75% crude extract 
concentration the blood coagulation were 1.8 
minutes, 2 minutes, and 1.9 minutes which suggest that after the administration of crude extract  until the time that it coagulates there were thinning formation but as compared it has 
less time of coagulation.
100% Crude Extract Concentration
Trials PlasmamL ExtractmL Calcium ChloridemL Coagulation Time1 0.2 0.1 0.3 4. 35 min2 0.2 0.1 0.3 4.14 min3 0.2 0.1 0.3 4.26 min
75% Crude Extract Concentration
Trials PlasmamL ExtractmL Calcium ChloridemL Coagulation Time(Minutes)1 0.2 0.1 0.3 1.8 min2 0.2 0.1 0.3 2.0 min3 0.2 0.1 0.3 1.9 min
50% Crude Extract Concentration
Trials PlasmamL ExtractmL Calcium ChloridemL Coagulation Time(Minutes)1 0.2 0.1 0.1 1.2 min2 0.2 0.1 0.1 1.15 min3 0.2 0.1 0.1 1.23 min
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Graph 4.1 Thinning	time	formations	of	experimental	and	
controlling	groups
Table 4.7 Degree	of	Freedom	with	Critical	Values	of	5%	
above	and	1%	below.
Table 4.8	F-test	o	ANOVA	Table	on	 the	 Inhibitory	Activity	of	Sandoricum	koetjape	Merr.	 (santol)	Leaf	
Extract	to	Blood	type	O	on	Fibrin	Formation	in	three	different	concentration	and	three	replications.
Table 4.6 Results	 of	 Multivariate	 Analysis	 plasma	 to	
different	 concentrations	 of	 100%,	 75%,	 and	 50%	 crude	
extract	concentration	in	three	trials.
The above table shows that at this point of 
concentration the coagulation was at 1.2, 1.15, 
and 1.23 minutes. This values was comparable with the negative control and suggests that there 
was no thinning formation occurred.
Above is a .05 level and below, .01 level. The 
computed F-value obtained for replication is 3. 
The tabular F(2,7) = 9.58 at .05 level and 4.74 at 
.01. Hence, the replication is insignificant. This 
means replication does not differ with each other.For treatment, the computed F-value 
obtained is 238 and the tabular F(2,7)= 9.58 at .05 
level and 4.74 at .01 level of probability, thus the 
By looking also at the graph (graph 4.1) it showed a visual representation of all the different concentration trial results compared with the 
positive control and negative control. It then directly showed that the longer time duration 
of coagulation was in 100% crude extract concentration which has almost the same value 
with the positive control.
The above table shows the total value for every trial which then used in solving F-test or two-way 
analysis of variance. As shown, the obvious highest 
time value was 100% concentration which then suggests that at this point of concentration there 
is a probable blood thinning.
Crude ExtractConcentrations Trial 1(Minutes) Trial 2(Minutes) Trial 3(Minutes) Coagulation time(Minutes)
100% 4.35 4.14 4.26 12.75
75% 1.8 2.0 1.9 5.7
50% 1.2 1.15 1.23 3.58Total 7.35 7.29 7.39 22
df
denominator
Numerator
            2                              2
7          9.58                          4.74          9.58                          4.74
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IV. RESULTS AND DISCUSSIONSThe experiment was then conducted for 
1 week. After three days of maceration and 
occasionally shaking to exhaust the constituents of the leaves then evaporated in a evaporating dish to let the methanol evaporates, the total yield collected of crude extract out of 60 grams 
of powdered leaves is 6.66 grams. The yield was then divided into three sets of concentration 
containing 2.2 grams of the yield crude extract. 
The 100% then had an equal amount of 2.2 grams, 
75% had 2.2 grams of crude extract the diluted to 
0.7mL of water, and 50% had then 2.2 grams of crude extract also diluted to a different volume of 
2mL. In every concentration and trials they were 
incubated to 370C in a water bath and checks 
every 30 minutes and recorded for any changes.
The above table serves as the baseline value 
of the blood plasma. This is the basis of the thinning time of blood after the administration of 
crude extract. As shown, the coagulation time of plasma before administration of plant extract was 
one minute.
The above table serves as the baseline value 
for the positive control using commercialized 
warfarin. As shown, the coagulation time of plasma after administration of warfarin was four 
minutes and one second.
Test Plasma(mL) 0.9% Saline (mL) Calcium chloride(mL) Coagulation Time(Minutes)Negative control 0.2 0.1 0.3 1.0
Test Plasma(mL) Warfarin 5mg(mL) Calcium chloride(mL) Coagulation Time(Minutes)Positive control 0.2 0.1 0.3 4.1 min
Table 4.1 Determination	 of	 baseline	 coagulation	 time	
using	saline	solution	for	the	control	of	plasma.
Table 4.3 Determination	 of	 coagulation	 time	 using	
methanol	extract	for	100%	concentration	of	crude	extract	
to	the	plasma	of	type	O	blood
Table 4.4 Determination	 of	 coagulation	 time	 using	
methanol	extract	for	75%	concentration	of	crude	extract	to	
the	plasma	of	type	O	blood.
Table 4.5 Determination	 of	 coagulation	 time	 using	
methanol	 extract	 for	 50%	concentration	 of	 crude	 extract	
of	a	blood	type	O.
Table 4.2 Determination	 of	 coagulation	 time	 using	
warfarin	5mg	to	a	blood	type	O.
This table shows that at 100% concentration 
the blood coagulation were 4.35 minutes, 4.14 
minutes , and 4.6 minutes which suggest that after the administration of crude extract until the time it coagulates there were  thinning formation which could be comparable to the time results of 
warfarin.
This table shows that at 75% crude extract 
concentration the blood coagulation were 1.8 
minutes, 2 minutes, and 1.9 minutes which suggest that after the administration of crude extract  until the time that it coagulates there were thinning formation but as compared it has 
less time of coagulation.
100% Crude Extract Concentration
Trials PlasmamL ExtractmL Calcium ChloridemL Coagulation Time1 0.2 0.1 0.3 4. 35 min2 0.2 0.1 0.3 4.14 min3 0.2 0.1 0.3 4.26 min
75% Crude Extract Concentration
Trials PlasmamL ExtractmL Calcium ChloridemL Coagulation Time(Minutes)1 0.2 0.1 0.3 1.8 min2 0.2 0.1 0.3 2.0 min3 0.2 0.1 0.3 1.9 min
50% Crude Extract Concentration
Trials PlasmamL ExtractmL Calcium ChloridemL Coagulation Time(Minutes)1 0.2 0.1 0.1 1.2 min2 0.2 0.1 0.1 1.15 min3 0.2 0.1 0.1 1.23 min
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Graph 4.1 Thinning	time	formations	of	experimental	and	
controlling	groups
Table 4.7 Degree	of	Freedom	with	Critical	Values	of	5%	
above	and	1%	below.
Table 4.8	F-test	o	ANOVA	Table	on	 the	 Inhibitory	Activity	of	Sandoricum	koetjape	Merr.	 (santol)	Leaf	
Extract	to	Blood	type	O	on	Fibrin	Formation	in	three	different	concentration	and	three	replications.
Table 4.6 Results	 of	 Multivariate	 Analysis	 plasma	 to	
different	 concentrations	 of	 100%,	 75%,	 and	 50%	 crude	
extract	concentration	in	three	trials.
The above table shows that at this point of 
concentration the coagulation was at 1.2, 1.15, 
and 1.23 minutes. This values was comparable with the negative control and suggests that there 
was no thinning formation occurred.
Above is a .05 level and below, .01 level. The 
computed F-value obtained for replication is 3. 
The tabular F(2,7) = 9.58 at .05 level and 4.74 at 
.01. Hence, the replication is insignificant. This 
means replication does not differ with each other.For treatment, the computed F-value 
obtained is 238 and the tabular F(2,7)= 9.58 at .05 
level and 4.74 at .01 level of probability, thus the 
By looking also at the graph (graph 4.1) it showed a visual representation of all the different concentration trial results compared with the 
positive control and negative control. It then directly showed that the longer time duration 
of coagulation was in 100% crude extract concentration which has almost the same value 
with the positive control.
The above table shows the total value for every trial which then used in solving F-test or two-way 
analysis of variance. As shown, the obvious highest 
time value was 100% concentration which then suggests that at this point of concentration there 
is a probable blood thinning.
Crude ExtractConcentrations Trial 1(Minutes) Trial 2(Minutes) Trial 3(Minutes) Coagulation time(Minutes)
100% 4.35 4.14 4.26 12.75
75% 1.8 2.0 1.9 5.7
50% 1.2 1.15 1.23 3.58Total 7.35 7.29 7.39 22
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denominator
Numerator
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treatment is significant. This means the treatment of different concentration of crude extract such 
as 100%, 75%, and 50% really differs with each 
other because the time of 100% crude extract is 
the highest time of blood thinning.
The computed F-value for treatment is 373.83 
with degrees of freedom 2,7. For replication, the 
computed F-value obtained is 1.5 with degrees of 
freedom 2,7. The former F-value is significant at 
0.5 and 0.1 levels of probability and the latter, not 
significant. This means the treatment of different crude extract concentration upon administration 
to the blood plasma really differ. Since these are the statistical results, the null hypothesis was 
then accepted. 
V. Summary of Findings and ConclusionsThe purpose of the study was to determine the anti-coagulant activity of Sandoricum koetjape 
Merr. leaves extract on type O blood plasma and 
had a specific aims to (1) determine the thinning formation of blood in minutes in relation to 
the (1.1) baseline mean value of blood: type O 
which then in table 4.1 shows the coagulation time of plasma without the induction of plant extract is one minute which indicates that there 
is no anticoagulation or blood thinning occurred. 
(1.2) experimental group (1.2.1) blood type O 
with 100% of crude extract concentration that there was a constant time of blood coagulation 
at a total time of 12.75  minutes which suggest that after the induction of crude extract until the time it coagulated there is a thinning formation which higher compared to the time results of 
warfarin, 75% crude extract concentration  with 
total time of 5.7 minutes which indicate also that between the inductions of crude extract until to the coagulation time of the plasma there was 
actually thinning formation occurred, and at 50% crude extract concentration which has the lowest time among other concentration to coagulate, this indicates that the thinning formation at a 
total time of 3.58 where the concentration is 
low compared to 100% and 75% crude extract 
concentration.
In comparing the viscosity of the blood plasma after administration of plant extract The viscosity between the blood plasma of type O blood and warfarin containing plasma was based under researcher’s observation, where blood plasma containing warfarin was more 
viscous than to plasma with crude extract. In 
graph 4.1 where the two controls is compared, the time interval shows that warfarin based on observation was rapid acting with short duration of time because coagulation was observed for at least four minutes compare to the other control 
which has 0.9% saline as negative control solution 
with one minute. Therefore at the baseline mean of blood plasma indicates the level of control for the preceding experiments where the time of coagulation was 1 minute so, if the preceding experiment exceeds the time of control then there 
is a thinning activity of blood plasma. For the 
positive control using commercialized warfarin 
which therefore gave a positivity at 4 minutes.Among the three crude extract concentration 
where 100% has the highest probability of anticoagulation therefore could be used as an 
anticoagulant. The treatment concludes that the 
study was significant though, the results shown in 
the replication was not significant could be due to 
human error.  
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other because the time of 100% crude extract is 
the highest time of blood thinning.
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ABSTRACT
This theoretical article atlases the theory of choice preference in research. This is initially induced from my experiences and supplemented with: (1) confession of other 
researchers; and (2) available literature. I exploited classical and pragmatic grounded 
theory (GT) that is modified to suit the need of the study. This type of GT is coined as 
“experience-based theory building”. Initially inductive, it amalgamated: (1) deduction; 
(2) abduction; and (3) retroduction. It obtained: (1) 13 Level I basic concepts: monetary, time, formal education, non-formal training, informal learning experience, exposure to alternative form of research, no exposure to the alternative form of 
research, acceptance, respect, disrespect, denial, open and close system; (2) 7 Level II subcategories or constructs: personal, socio-cultural, economic, educational, learning exposure, continuum of exposure to the alternative form of research tradition, action 
and acceptance system; and (3) 5 Level III theoretical categories: philosophical stance, 
influences, exposure, preferred research tradition and judgment. Choice preference 
was identified as the core category that interlaced the different theoretical categories, 
constructs and basic concepts. Choice preference is an individual process and cannot 
be imposed. The interaction between the acceptance system and exposure curbs the 
actions: (1) respect; (2) acceptance; (3) denial; and (4) disrespect. This is categorically 
interpreted as: (1) true wisdom; (2) informed; (3) ignorance; and (4) elitism. Choice preference engages with the: (1) expenditure to the preferred form; and (2) judgment 
to the alternative form. This is the synergy of learning exposure, spelled in its formal, informal and non-formal form, and philosophical stance that is shaped with personal, 
economic, educational and socio-cultural influences.
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I. INTRODUCTIONThis theoretical article enunciates choice 
preference theory in research. This theory was induced from the: (1) researcher’s experience as a qualitative researcher being challenged by quantitative practitioners; (2) available literature 
regarding the debate between and within research traditions; and (3) experiences and 
insights of other practitioners. This theory is an attempt to put the quantitative-qualitative divide 
in academia to an end. Though argumentation helped in the development of both disciplines, 
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